MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Atrium Therapeutics, Inc. (RNA)

Atrium Therapeutics, Inc. (RNA)

|||

Balance Sheets Overview

Current Ratio
872.96%
Quick Ratio
872.96%
Cash Ratio
229.57%
Debt to Asset Ratio
23.51%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short term investments
    • Cash and cash equivalents
    • Other current assets
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Deferred revenue, net of current...
    • Deferred revenue, current portio...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
72,334
267,849
382,517
350,158
Marketable securities
-
-
1,314,352
1,525,678
Collaboration receivables
-
15,000
-
-
Short term investments
191,566
-
-
-
Prepaid assets
4,506
2,578
-
-
Restricted cash, current portion
311
-
-
-
Prepaid and other current assets
-
-
101,598
90,181
Other current assets
6,334
138
-
-
Total current assets
275,051
285,565
1,798,467
1,966,017
Restricted cash, net of current portion
106
415
2,797
2,798
Property and equipment, net
4,066
4,337
23,333
21,504
Right-of-use asset
1,289
2,043
51,278
52,848
Other assets
-
-
82,175
91,042
Total assets
280,512
292,360
1,958,050
2,134,209
Accounts payable
3,513
807
12,403
9,626
Accrued liabilities
13,312
6,983
-
-
Accrued expenses and other liabilities
-
-
157,466
137,163
Accrued compensation
3,962
2,091
-
-
Lease liabilities
1,683
2,680
3,938
3,967
Deferred revenue, current portion
9,038
9,344
21,639
19,123
Total current liabilities
31,508
21,905
195,446
169,879
Lease liabilities, net of current portion
-
-
45,313
45,999
Deferred revenue, net of current portion
33,653
36,351
28,691
32,066
Other long-term liabilities
775
0
-
-
Total liabilities
65,936
58,256
269,450
247,944
Common stock, 0.001 par value 400,000 shares authorized 17,106 shares issued and outstanding as of june 30, 2026, and no shares authorized, issued, or outstanding as of december 31, 2025
16
16
15
15
Additional paid-in capital
222,853
221,960
3,263,720
3,225,078
Accumulated deficit
-8,058
12,128
-1,577,697
-1,340,596
Accumulated other comprehensive loss, net
-235
-
2,562
1,768
Net investment from former parent
0
0
-
-
Total stockholders' equity / former parent's deficit
214,576
234,104
1,688,600
1,886,265
Total liabilities and stockholders' equity / former parent's deficit
280,512
292,360
1,958,050
2,134,209
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short terminvestments$191,566K Cash and cashequivalents$72,334K (-70.34%↓ Y/Y)Other current assets$6,334K (-85.24%↓ Y/Y)Prepaid assets$4,506K (-71.80%↓ Y/Y)Restricted cash, currentportion$311K Total current assets$275,051K (-78.01%↓ Y/Y)Property and equipment,net$4,066K (-80.20%↓ Y/Y)Right-of-use asset$1,289K (-69.51%↓ Y/Y)Restricted cash, net ofcurrent portion$106K (-96.21%↓ Y/Y)Total assets$280,512K (-79.51%↓ Y/Y)Total liabilities andstockholders' equity / former...$280,512K (-79.51%↓ Y/Y)Total stockholders'equity / former...$214,576K (-82.01%↓ Y/Y)Total liabilities$65,936K (-62.59%↓ Y/Y)Accumulated deficit-$8,058K (99.31%↑ Y/Y)Accumulated othercomprehensive loss, net-$235K (-113.22%↓ Y/Y)Additional paid-in capital$222,853K (-90.55%↓ Y/Y)Deferred revenue, net ofcurrent portion$33,653K (-15.85%↓ Y/Y)Total currentliabilities$31,508K (-76.67%↓ Y/Y)Other long-termliabilities$775K Common stock, 0.001 parvalue 400,000 shares...$16K (33.33%↑ Y/Y)Accrued liabilities$13,312K Deferred revenue,current portion$9,038K (-33.23%↓ Y/Y)Accrued compensation$3,962K (-78.52%↓ Y/Y)Accounts payable$3,513K (-10.25%↓ Y/Y)Lease liabilities$1,683K (-57.12%↓ Y/Y)